Table 2.
Category and items | Value, n (%) | Behavior change technique score, mean (SD) | |
Primary prevention | 13 (43) | 5.31 (2.93) | |
Genetics | |||
|
Risk | 12 (40) | 5.67 (2.46) |
|
Screening | 5 (16) | 6.40 (2.70) |
Early detection | |||
|
Mammography | 12 (40) | 5.25 (2.45) |
|
Clinical breast examination | 10 (33) | 5.10 (2.28) |
|
Self-breast examination | 21 (70) | 5.04 (2.58) |
|
Symptoms | 21 (70) | 5.38 (2.52) |
Diagnosis | |||
|
Stage | 3 (10) | 8.00 (1.73) |
|
Type of tumor | 2 (6) | 7.50 (2.12) |
|
Prognosis | 3 (10) | 7.33 (1.53) |
Management/therapeutics | |||
|
Treatment options | 7 (23) | 6.71 (2.50) |
|
Side effects | 4 (13) | 6.25 (2.50) |
|
Care management | 6 (20) | 6.33 (2.50) |
|
Prevention pills | 3 (10) | 8.33 (1.15) |
End-of-life care/hospice | |||
|
Survivorship | 4 (13) | 8.25 (0.96) |
|
End-of-life care/hospice | 0 (0) | N/Aa |
Research/science | |||
|
Biological process | 4 (13) | 7.00 (3.46) |
|
Clinical trials | 3 (10) | 7.00 (1.00) |
|
Research referenced | 9 (30) | 6.00 (2.94) |
aN/A: not applicable.